HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
scientists at a table

New Funding Opportunity to Repurpose Existing Drugs or Biologics

NCATS released a funding opportunity to explore a potential new use of an existing drug or biologic through its Bench-to-Clinic Repurposing initiative.

Christopher P. Austin, M.D., Anne R. Pariser, M.D., Ronald J. Bartek, Petra Kaufmann, M.D., M.Sc., and Annie Kennedy

NCATS Unveils Patient-Focused Therapy Development Toolkit

NCATS showcases web-based platform of patient-focused rare diseases research resources at NIH event in September.

Person reading the newsletter on a tablet

October E-Newsletter Now Available

Read about the NCATS Toolkit for Patient-Focused Therapy Development, a TRND-FDA partnership to fund rare diseases studies, NIH efforts to increase diversity in research, and more.

Two scientists work in a lab

NCATS and FDA To Fund Rare Disease Studies

NCATS’ TRND program is supporting two natural history studies on how specific rare diseases progress over time.

A human brain tumor mass that has been engrafted into and is actively growing within a rat brain slice explant.

Collaboration Aims to Improve Brain Cancer Drug Testing

CTSA Program-supported scientists work to develop novel technique to test drugs against the most common form of brain cancer.

More Center News

Michael G. Kurilla Joins NCATS

Michael G. Kurilla will serve as director of the Division of Clinical Innovation.

Disease Modeling Awards

NCATS announced 13 awards to develop 3-D tissue chip research platforms

  • Facebook icon
  • Twitter icon
  • YouTube icon

Assay Guidance Manual

Assay Guidance Manual Cover

Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.